Frontiers in Immunology,
Год журнала:
2025,
Номер
15
Опубликована: Янв. 20, 2025
Acute
lung
injury
(ALI)
is
a
common
respiratory
disease,
Cordycepin
has
been
reported
to
reduce
ALI,
which
an
effective
component
in
Cordyceps
militaris
solid
medium
extract
(CMME).
Therefore,
we
aimed
explore
the
alleviating
effect
and
mechanism
of
CMME
on
ALI.
This
study
evaluated
lipopolysaccharide
(LPS)-induced
ALI
mice
by
analyzing
intestinal
flora
metabolomics
its
potential
mechanism.
We
assessed
pulmonary
changes,
inflammation,
oxidative
stress,
macrophage
neutrophil
activation
levels,
then
analyzed
gut
microbiota
through
16S
rRNA
profile
UPLC-QTOF/MS.
The
results
showed
that
treatment
improved
injury,
reduced
inflammatory
factors
stress
decreased
recruitment.
revealed
significantly
increased
richness
diversity
abundance
Bacteroides
compared
with
Mod
group
significantly.
Metabolic
analysis
indicated
reversed
levels
differential
metabolites
may
ameliorate
purine
metabolism,
nucleotide
bile
acid
(BA)
did
reverse
changes
BA
mice,
were
associated
flora.
improve
regulating
correcting
metabolic
disorders,
providing
new
insights
into
action.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Янв. 17, 2024
The
lungs
were
long
thought
to
be
sterile
until
technical
advances
uncovered
the
presence
of
lung
microbial
community.
microbiome
healthy
is
mainly
derived
from
upper
respiratory
tract
(URT)
but
also
has
its
own
characteristic
flora.
selection
mechanisms
in
lung,
including
clearance
by
coughing,
pulmonary
macrophages,
oscillation
cilia,
and
bacterial
inhibition
alveolar
surfactant,
keep
transient
mobile,
which
different
other
organs.
bacteriome
been
intensively
studied
recently,
relatively
little
research
focused
on
mycobiome
virome.
This
up-to-date
review
retrospectively
summarizes
microbiome's
history,
composition,
function.
We
focus
interaction
with
oropharynx
gut
emphasize
role
it
plays
innate
adaptive
immune
responses.
More
importantly,
we
multiple
diseases,
asthma,
chronic
obstructive
disease
(COPD),
fibrosis,
bronchiectasis,
pneumonia.
impact
coronavirus
2019
(COVID-19)
cancer
comprehensively
studied.
Furthermore,
summarizing
therapeutic
potential
diseases
examining
shortcomings
field,
propose
an
outlook
direction
research.
Biomedicine & Pharmacotherapy,
Год журнала:
2023,
Номер
165, С. 115007 - 115007
Опубликована: Июнь 15, 2023
Plant-derived
exosome-like
nanoparticles
(ELNs)
have
been
proposed
as
a
novel
therapeutic
tool
for
preventing
human
diseases.
However,
the
number
of
well-verified
plant
ELNs
remains
limited.
In
this
study,
microRNAs
in
derived
from
fresh
Rehmanniae
Radix,
well-known
traditional
Chinese
herb
treating
inflammatory
and
metabolic
diseases,
were
determined
by
using
microRNA
sequencing
to
investigate
active
components
protection
against
lipopolysaccharide
(LPS)-induced
acute
lung
inflammation
vivo
vitro.
The
results
showed
that
rgl-miR-7972
(miR-7972)
was
main
ingredient
ELNs.
It
exerted
stronger
protective
activities
LPS-induced
than
catalpol
acteoside,
which
are
two
chemical
markers
herb.
Moreover,
miR-7972
decreased
production
pro-inflammatory
cytokines
(IL-1β,
IL-6,
TNF-α),
reactive
oxygen
species
(ROS)
nitric
oxide
(NO)
LPS-exposed
RAW264.7
cells,
thereby
facilitating
M2
macrophage
polarization.
Mechanically,
downregulated
expression
G
protein-coupled
receptor
161
(GPR161),
activating
Hedgehog
pathway,
inhibited
biofilm
form
Escherichia
coli
via
targeting
virulence
gene
sxt2.
Therefore,
R.
Radix
alleviated
GPR161-mediated
recovering
gut
microbiota
dysbiosis.
also
provided
new
direction
gaining
bioactivity
nucleic
acid
drugs
broadening
knowledge
on
cross-kingdom
physiological
regulation
through
miRNAs.
Frontiers in Medicine,
Год журнала:
2023,
Номер
10
Опубликована: Ноя. 21, 2023
Sepsis
is
a
systemic
inflammatory
disease
caused
by
severe
infections
that
involves
multiple
organs,
among
which
the
lung
most
susceptible,
leaving
patients
highly
vulnerable
to
acute
injury
(ALI).
Refractory
hypoxemia
and
respiratory
distress
are
classic
clinical
symptoms
of
ALI
sepsis,
has
mortality
rate
40%.
Despite
extensive
research
on
mechanisms
exact
pathological
process
not
fully
understood.
This
article
reviews
advances
in
pathogenesis
sepsis
focusing
treatment
regimens
adopted
practice
for
corresponding
molecular
mechanisms.
review
can
only
contribute
theories
but
also
recommend
new
strategies
related
injuries.
Clinical Science,
Год журнала:
2023,
Номер
137(8), С. 645 - 662
Опубликована: Апрель 1, 2023
Abstract
Both
a
leaky
gut
(a
barrier
defect
of
the
intestinal
surface)
and
dysbiosis
change
in
microbial
population)
are
intrinsic
to
sepsis.
While
sepsis
itself
can
cause
dysbiosis,
worsen
The
syndrome
refers
status
with
which
there
is
an
increased
permeability
allowing
translocation
molecules
from
into
blood
circulation.
It
not
just
symptom
gastrointestinal
involvement,
but
also
underlying
that
develops
independently,
its
presence
could
be
recognized
by
detection,
blood,
lipopolysaccharides
(1→3)-β-D-glucan
(major
components
microbiota).
Gut-dysbiosis
consequence
reduction
some
bacterial
species
microbiome,
as
mucosal
immunity
defect,
caused
hypoperfusion,
immune
cell
apoptosis,
variety
enteric
neuro-humoral-immunity
responses.
A
bacteria
produce
short-chain
fatty
acids
barriers,
leading
pathogen
molecules,
circulation
where
it
causes
systemic
inflammation.
Even
fungi
might
human
patients
sepsis,
even
though
this
has
been
consistently
observed
murine
models
probably
because
longer
duration
antibiotic
use
patients.
virobiome
partly
consists
bacteriophages
detectable
contents
different
between
normal
hosts.
These
alterations
altogether
interesting
target
for
adjuvant
therapies,
e.g.,
faecal
transplantation
or
probiotic
therapy.
Here,
current
information
on
along
potential
biomarkers,
new
treatment
strategies,
future
research
topics
mentioned.
Abstract
It
has
been
convincingly
demonstrated
in
recent
years
that
isolated
acute
brain
injury
(ABI)
may
cause
severe
dysfunction
of
peripheral
extracranial
organs
and
systems.
Of
all
potential
target
systems,
the
lung
appears
to
be
most
vulnerable
damage
after
ABI.
The
pathophysiology
bidirectional
brain–lung
interactions
is
multifactorial
involves
inflammatory
cascades,
immune
suppression,
autonomic
system.
Indeed,
systemic
effects
mediators
patients
with
ABI
create
a
environment
(“first
hit”)
makes
secondary
procedures
enhance
inflammation,
such
as
mechanical
ventilation
(MV),
surgery,
infections
(“second
hit”).
Moreover,
accumulating
evidence
supports
knowledge
gut
microbiota
constitutes
critical
superorganism
an
organ
on
its
own,
potentially
modifying
various
physiological
functions
host.
Furthermore,
experimental
clinical
data
suggest
existence
communication
network
among
brain,
gastrointestinal
tract,
microbiome,
which
regulate
responses,
function,
behavior,
stress
also
named
“gut-microbiome–brain
axis.”
Additionally,
research
highlighted
crucial
interplay
between
intestinal
lungs,
referred
“gut-lung
axis,”
alterations
during
illness
could
result
bacterial
translocation,
sustained
injury,
pulmonary
fibrosis.
In
present
work,
we
aimed
further
elucidate
(ALI)
by
attempting
develop
“double-hit”
theory,
proposing
“triple-hit”
hypothesis,
focused
influence
gut–lung
axis
lung.
Particularly,
propose,
addition
sympathetic
hyperactivity,
blast
double-hit
dysbiosis
context
alter
axis,
resulting
development
or
aggravation
existing
ALI,
“third
hit.”
Pharmaceuticals,
Год журнала:
2024,
Номер
17(4), С. 472 - 472
Опубликована: Апрель 8, 2024
Sepsis-induced
acute
lung
injury
(ALI),
characterized
by
widespread
dysfunction,
is
associated
with
significant
morbidity
and
mortality
due
to
the
lack
of
effective
pharmacological
treatments
available
clinically.
Small-molecule
compounds
derived
from
natural
products
represent
an
innovative
source
have
demonstrated
therapeutic
potential
against
sepsis-induced
ALI.
These
small
molecules
may
provide
a
promising
alternative
treatment
option
for
This
review
aims
summarize
pathogenesis
sepsis
targets.
It
assembles
critical
updates
(from
2014
2024)
on
ALI,
detailing
their
sources,
structures,
effects,
mechanisms
action.
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Фев. 16, 2024
The
prevalence
rate
of
acute
respiratory
distress
syndrome
(ARDS)
is
estimated
at
approximately
10%
in
critically
ill
patients
worldwide,
with
the
mortality
ranging
from
17%
to
39%.
Currently,
ARDS
usually
higher
COVID-19,
giving
another
challenge
for
treatment.
However,
treatment
efficacy
far
satisfactory.
relationship
between
gut
microbiota
and
has
been
substantiated
by
relevant
scientific
studies.
not
only
changes
distribution
microbiota,
but
also
influences
intestinal
mucosal
barrier
through
alteration
microbiota.
modulation
can
impact
onset
progression
triggering
dysfunctions
inflammatory
response
immune
cells,
oxidative
stress,
cell
apoptosis,
autophagy,
pyroptosis,
ferroptosis
mechanisms.
Meanwhile,
may
influence
metabolic
products
In
this
review,
we
focus
on
how
further
function,
cellular
functions
related
signaling
pathways
during
ARDS.
roles
microbiota-derived
metabolites
development
occurrence
are
discussed.
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
175, С. 116773 - 116773
Опубликована: Май 21, 2024
Acute
lung
injury
(ALI)
and
acute
respiratory
distress
syndrome
(ARDS)
represent
a
significant
global
burden
of
morbidity
mortality,
with
being
the
primary
cause
death
in
affected
patients.
The
pathogenesis
injury,
however,
remains
complex
issue.
In
recent
years,
role
immune
system
has
attracted
extensive
attention
worldwide.
Despite
advancements
our
understanding
various
subtypes,
limitations
persist
both
prevention
treatment.
This
review
investigates
immunopathogenesis
ALI/ARDS,
aiming
to
elucidate
pathological
processes
mediated
by
dendritic
cells
(DCs),
natural
killer
(NK)
cells,
phagocytes,
neutrophils.
Furthermore,
article
expounds
on
critical
contributions
gut
microbiota,
inflammatory
pathways,
cytokine
storms
development
ALI/ARDS.